Since B3GNT8 was reported to function as an oncogene in several cancers26, 27, we also determined whether the off-target knockdown effect induced by CRISPR-Cas9 could affect biological behavior of Hela cells derived from cervical cancer. Here, B3GNT8 is linked to cervical carcinoma.